1. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes;Rosenberg, S.A.; Spiess, P.; Lafreniere, R.;Science,1992
2. Use of tumor-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer;Rosenberg, S.A.; Packard, B.S.; Aebersold, P.; Solomon, D.; Topalian, S.L.; Toy, S.T.,1988
3. Tumour-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer;Kradin, R.L.; Lazarus, D.S.; Dubinett, S.M.; Gifford, J.; Grove, B.H.; Kurnick, J.T.;Lancet,1989
4. Production of stable cytolytic T-cell clones directed against autologous human melanoma;Herin, M.; Lemone, C.; Weynants, P.; Vessiere, F.; van Pei, A.; Knuth, A.;In J Cancer,1987
5. Autologous tumorspecific cytotoxic T lymphocytes in the infiltrate of human metastic melanomas. Activation by interleukin-2 and autologous tumor cells, and involvement of the T cell receptor;Itoh, K.; Platsoucas, C.D.; Balch, C.M.;JExpMed,1988